Regulation of Cd4 T Cell Responses to Il-7 by Ifn-Alpha and Tgf-Beta in Treated Hiv Disease

Total Page:16

File Type:pdf, Size:1020Kb

Regulation of Cd4 T Cell Responses to Il-7 by Ifn-Alpha and Tgf-Beta in Treated Hiv Disease REGULATION OF CD4 T CELL RESPONSES TO IL-7 BY IFN-ALPHA AND TGF-BETA IN TREATED HIV DISEASE By: THAO NGUYEN Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Advisor: Scott F. Sieg, PhD Department of Pathology Immunology Training Program CASE WESTERN RESERVE UNIVERSITY JANUARY 2017 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES THAO P NGUYEN Candidate for the degree of Doctor of Philosophy* Committee Chair CLIFFORD HARDING, MD/PhD Committee Member SCOTT SIEG, PhD Committee Member MICHAEL LEDERMAN, MD Committee Member DONALD ANTHONY, MD/PhD Committee Member JOHN TILTON, MD Committee Member CLIVE HAMLIN, PhD Date of Defense November 21, 2016 *We also certify that written approval has been obtained for any proprietary material contained therein. ii I dedicate this dissertation to my sister and late mother. iii Table of contents Page Dedication iii Table of contents iv List of figures and tables viii Acknowledgements x List of abbreviations xi Abstract 1 Chapter 1: Introduction 2 HIV pathogenesis 2 CD4 T cell count recovery in HIV infection following ART initiation 9 Homeostatic proliferation in response to interleukin-7 is a mediator of T cell 10 recovery The role of IFN-I in treated HIV infection 14 The anti-viral and anti-proliferative functions of IFN-I 14 TGF-β and additional cytokines that may contribute to low CD4 T cell count 17 recovery in treated HIV infected patients Chapter 2: Interferon-α inhibits CD4 T cells proliferation and signaling in 19 response to IL-7 and IL-2 Abstract 19 Introduction 19 Methods 21 Cells and cell culture Flow cytometry Statistical analyses iv Results 24 IFN-α impairs IL-7-induced proliferation responses and diminishes 24 cellular function in CD4+ T cells IFN-α diminishes T cell viability 29 IFN-α inhibits P-Akt but not P-STAT5 in IL-7-treated cells 31 IFN-α inhibits P-Akt signaling that is induced by IL-2 but not by SDF-1 33 Inhibition of P-Akt or P-STAT5 blocks cellular proliferation and 35 function Discussion 37 Chapter 3: Diminished CD4 T cell responsiveness to IL-7 in immune 42 failure subjects is related to diminished CD127 expression and increased IFN-α expression Abstract 42 Introduction 43 Methods 45 Patients Peripheral blood mononuclear cell and T-cell isolation mRNA analyses Stimulation conditions Flow cytometry Statistical analyses Results 48 IL-7 mediated proliferation and induction of CD25 are diminished in 48 CD4+ T cells from immune failure patients CD4+ T cells from immune failure patients exhibit decreased CD127 53 expression and increased immune activation v Interferon-stimulated gene and IFN-α mRNA expression are increased in 53 CD3+T cells from immune failure patients Diminished IL-7 responsiveness in immune failure patients is related to 55 expression of CD127 and IFN-α IFN-α responsiveness is not diminished in CD4+ T cells from immune failure 57 patients Discussion 59 Chapter 4: TGF-β inhibits IL-7 induced proliferation in memory but not 64 naive CD4 T cells Abstract 64 Introduction 64 Methods 67 Peripheral blood mononuclear cell and CD4 T cell subset isolation Stimulation conditions Flow cytometry Statistical analyses Results 69 TGF-β inhibits memory but not naive CD4 T cell proliferation in response 69 to IL-7 TGF-β suppresses IL-7 mediated induction of c-myc expression in naive 72 and memory CD4 T cells TGF-β does not inhibit IL-7 receptor signaling in memory CD4 T cells 74 and enhances S6 kinase signaling in naive CD4 T cells GSK-3 inactivation partially overcomes TGF-β-mediated inhibition of 75 IL-7-induced proliferation and c-myc induction in memory CD4 T cells Discussion 78 Chapter 5: Discussion and future directions 71 vi Diminished responsiveness to IL-7 may contribute to poor 81 = CD4 T cell count recovery in treated HIV infection The role of IFN-I in poor CD4 T cell count recovery in treated 84 HIV infection TGF-β selectively inhibits memory CD4 T cell proliferation in response to 86 IL-7 IFN-α and TGF-β utilize different mechanisms to inhibit IL-7-induced 87 proliferation in CD4 T cells Literature cited 89 vii List of Tables and Figures Page Table 1. Clinical characteristics and immune phenotypes of subjects 46 Figure 1.1 CD4 T cell loss and viral load in HIV infection 2 Figure 1.2 Proposed contributors to HIV-associated immune activation 6 Figure 1.3. HIV life cycle showing sites of action of different classes of 8 antiretroviral drug Figure 1.4 CD4 T cell recovery is highly variable and related to nadir 10 CD4 T cell count Figure 1.5 IL-7 receptor signaling promotes cell survival and drives proliferation 11 Figure 2.1. IFN inhibits IL-7-induced proliferation 25 Figure 2.2. The magnitude of IFN-α mediated inhibition of IL-7 induced 26 proliferation is dose dependent Figure 2.3 Pre-incubation of CD4+ T cells in IFN-α plus IL-7 reduces 27 T cell function compared with pre-incubation of cells in IL-7 alone Figure 2.4 Gating strategy to assess viability 29 Figure 2.5 IFN-α causes cell death, primarily in nondividing T cells, 30 in IL-7-treated cell cultures Figure 2.6 IFN-α impairs P-Akt but not P-STAT5 signaling in IL-7-treated cells 31 Figure 2.7 Impaired responses to IL-2 but not SDF-1 in CD4 cells exposed 34 to IFN-α Figure 2.8 Inhibition of PI3K or STAT5 reduced cell proliferation, decreased 35 functionality, and enhanced cell death in cells treated with IL-7. Figure 3.1 CD4+ T-cell responses to IL-7 are diminished in immune failure 49 patients Figure 3.2 CD4- T cell proliferation in response to IL-7 is diminished in IF 51 subjects Fig. 3.3 Induction of P-STAT5 and P-Akt in response to IL-7 52 Fig. 3.4 T cells from immune failure patients exhibit increased expression of 53 viii interferon stimulated genes and IFN-α Fig. 3.5 IL-7 induced CD25 expression is related to expression of CD127 55 Fig. 3.6 CD4+ T- cell responses to IFN-α were not diminished in immune 57 failure patients. Fig. 3.7 IFN-α mediated induction of cell death in CD4 T cell subsets 59 Figure 4.1 TGF-β differentially affects naive and memory CD4 T cell 69 proliferation in response to IL-7 Figure 4.2 TGF-β inhibits IL-7 induced % divided and proliferation index 71 in memory CD4 T cells Figure 4.3 TGF-β inhibits IL-7 mediated induction of c-myc expression 72 in naive and memory CD4 T cells Figure 4.4 TGF-β does not inhibit IL-7 receptor signaling in memory 74 CD4 T cells and enhances S6 phosphorylation in naïve CD4 T cells Figure 4.5 TGF-β mediated inhibition of IL-7 induced proliferation and 76 c-myc expression in memory CD4 T cells is reversed by the inactivation of GSK-3 Figure 5.1 Differential mechanisms of inhibition of IL-7 induced 88 proliferation by TGF-β and IFN-α ix Acknowledgements I would like to thank my PI, Dr. Scott Sieg. During my time at Case, Scott provided a wonderful learning environment that allowed me develop as a scientist. He is encouraging, genuine, thoughtful and a great role model for me. I would also like to thank Dr. Michael Lederman for his guidance and feedback. I find Michael exceptional because his actions demonstrate his dedication to helping others develop their projects and careers on top of his various responsibilities. I would like to thank Dr. Clifford Harding, Dr. Donald Anthony and Dr. John (Chip) Tilton for their guidance and help over the years while serving on my thesis committee. Dr. Harding has done an excellent job in his role as the chair of my committee by always being clear and organized. I appreciate Dr. Don Anthony and Dr. John Tilton for their guidance in helping me think about my project as well as my career goals. Finally, I would like to thank my collaborators and the members of the Sieg and Lederman labs. I want to thank Dr. Supriya Shukla and Dr. Robert Asaad for their contribution to my immune failure project. I would like to thank Doug Bazdar for teaching me various laboratory techniques as well as always being available to help me in the lab. Overall, the contributions from all the mentioned people have resulted in a pleasant experience in my journey to obtaining my degree. x List of Abbreviations AIDS -acquired immune deficiency syndrome ART-antiretroviral therapy CMV- Cytomegalovirus CH-CHIR-99021 c-myc- myelocytomatosis EBV- Epstein–Barr virus GSK-3-glycogen synthase kinase 3 HC-healthy control HIV-human immunodeficiency virus IFI16-gamma interferon inducible protein 16 IgA-immunoglobulin A IL-1β- interleukin-1beta IL-2-interleukin-2 IL-6-interleukin-6 IL-7-interleukin-7 IL-10- interleukin 10 IF-immune failure IS-immune success IP-10-gamma interferon inducible protein 10 IRF-7- interferon regulatory factor 7 IRF-9- interferon regulatory factor 9 ISG-interferon stimulated genes xi ISGF-3- interferon stimulated gene factor-3 ISRE- IFN stimulatory response elements LAV-lymphadenopathy-associated virus LN-lymph node Mx-myxovirus OAS- 2’, 5’-oligoadenylate synthetase PBMCs-peripheral blood mononuclear cells pDCs-plasmacytoid dendritic cells PKR-protein kinase R SCID- severe combined immunodeficiency SDF-1-stromal derived factor 1 SEB- Staphylococcal Enterotoxin B STAT5- signal transducer and activator of transcription 5 TCR-t cell receptor TGF-β- transforming growth factor-beta TLR-toll like receptor TRECs- T cell rearrangement excision circles TYK2-tyrosine kinase 2 xii The Regulation of Response to IL-7 by IFN-alpha and TGF-beta in Treated HIV Disease Abstract by THAO NGUYEN Antiretroviral therapy administration has nearly eliminated acquired immune deficiency syndrome (AIDS) -related mortality in human immunodeficiency virus (HIV) infected patients.
Recommended publications
  • The Role of SAMHD1 in Restriction and Immune Sensing of Retroviruses and Retroelements
    The role of SAMHD1 in restriction and immune sensing of retroviruses and retroelements Die Rolle von SAMHD1 in der Restriktion und Immunerkennung von Retroviren und Retroelementen Der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg zur Erlangung des Doktorgrades Dr. rer. nat. vorgelegt von Alexandra Herrmann aus Biberach an der Riß Als Dissertation genehmigt von der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Tag der mündlichen Prüfung: 31.07.2018 Vorsitzender des Promotionsorgans: Prof. Dr. Georg Kreimer Gutachter: Prof. Dr. Lars Nitschke Prof. Dr. Manfred Marschall Table of content Table of content I. Summary ......................................................................................................................... 1 I. Zusammenfassung ......................................................................................................... 3 II. Introduction ..................................................................................................................... 5 1. The human immunodeficiency virus .................................................................................... 5 2. Transposable elements ......................................................................................................... 7 3. Host restriction factors ........................................................................................................ 10 4. The restriction factor SAMHD1 ..........................................................................................
    [Show full text]
  • Canine Influenza Virus Is Mildly Restricted by Canine Tetherin Protein
    viruses Article Canine Influenza Virus is Mildly Restricted by Canine Tetherin Protein Yun Zheng 1,2,3,†, Xiangqi Hao 1,2,3,†, Qingxu Zheng 1,2,3, Xi Lin 1,2,3, Xin Zhang 1,2,3, Weijie Zeng 1,2,3, Shiyue Ding 1, Pei Zhou 1,2,3,* and Shoujun Li 1,2,3,* 1 College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China; [email protected] (Y.Z.); [email protected] (X.H.); [email protected] (Q.Z.); [email protected] (X.L.); [email protected] (X.Z.); [email protected] (W.Z.); [email protected] (S.D.) 2 Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases, Guangzhou 510642, China 3 Guangdong Provincial Pet Engineering Technology Research Center, Guangzhou 510642, China * Correspondence: [email protected] (P.Z.); [email protected] (S.L.) † These authors contributed equally to this work. Received: 10 July 2018; Accepted: 10 October 2018; Published: 16 October 2018 Abstract: Tetherin (BST2/CD317/HM1.24) has emerged as a key host-cell ·defence molecule that acts by inhibiting the release and spread of diverse enveloped virions from infected cells. We analysed the biological features of canine tetherin and found it to be an unstable hydrophilic type I transmembrane protein with one transmembrane domain, no signal peptide, and multiple glycosylation and phosphorylation sites. Furthermore, the tissue expression profile of canine tetherin revealed that it was particularly abundant in immune organs. The canine tetherin gene contains an interferon response element sequence that can be regulated and expressed by canine IFN-α.
    [Show full text]
  • Tetherin/BST-2 Promotes Dendritic Cell Activation and Function During Acute Retrovirus Infection Received: 21 October 2015 Sam X
    www.nature.com/scientificreports OPEN Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection Received: 21 October 2015 Sam X. Li1,2, Bradley S. Barrett1, Kejun Guo1, George Kassiotis3, Kim J. Hasenkrug4, Accepted: 06 January 2016 Ulf Dittmer5, Kathrin Gibbert5 & Mario L. Santiago1,2 Published: 05 February 2016 Tetherin/BST-2 is a host restriction factor that inhibits retrovirus release from infected cells in vitro by tethering nascent virions to the plasma membrane. However, contradictory data exists on whether Tetherin inhibits acute retrovirus infection in vivo. Previously, we reported that Tetherin-mediated inhibition of Friend retrovirus (FV) replication at 2 weeks post-infection correlated with stronger natural killer, CD4+ T and CD8+ T cell responses. Here, we further investigated the role of Tetherin in counteracting retrovirus replication in vivo. FV infection levels were similar between wild-type (WT) and Tetherin KO mice at 3 to 7 days post-infection despite removal of a potent restriction factor, Apobec3/Rfv3. However, during this phase of acute infection, Tetherin enhanced myeloid dendritic cell (DC) function. DCs from infected, but not uninfected, WT mice expressed significantly higher MHC class II and the co-stimulatory molecule CD80 compared to Tetherin KO DCs. Tetherin-associated DC activation during acute FV infection correlated with stronger NK cell responses. Furthermore, Tetherin+ DCs from FV-infected mice more strongly stimulated FV-specific CD4+ T cells ex vivo compared to Tetherin KO DCs. The results link the antiretroviral and immunomodulatory activity of Tetherin in vivo to improved DC activation and MHC class II antigen presentation. Restriction factors are host-encoded type I interferon-stimulated genes (ISG) that directly inhibit virus replication1.
    [Show full text]
  • Modulating Antiviral Response Via CRISPR–Cas Systems
    viruses Review Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems Sergey Brezgin 1,2,3,† , Anastasiya Kostyusheva 1,†, Ekaterina Bayurova 4 , Elena Volchkova 5, Vladimir Gegechkori 6 , Ilya Gordeychuk 4,7, Dieter Glebe 8 , Dmitry Kostyushev 1,3,*,‡ and Vladimir Chulanov 1,3,5,‡ 1 National Medical Research Center of Tuberculosis and Infectious Diseases, Ministry of Health, 127994 Moscow, Russia; [email protected] (S.B.); [email protected] (A.K.); [email protected] (V.C.) 2 Institute of Immunology, Federal Medical Biological Agency, 115522 Moscow, Russia 3 Scientific Center for Genetics and Life Sciences, Division of Biotechnology, Sirius University of Science and Technology, 354340 Sochi, Russia 4 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia; [email protected] (E.B.); [email protected] (I.G.) 5 Department of Infectious Diseases, Sechenov University, 119991 Moscow, Russia; [email protected] 6 Department of Pharmaceutical and Toxicological Chemistry, Sechenov University, 119991 Moscow, Russia; [email protected] 7 Department of Organization and Technology of Immunobiological Drugs, Sechenov University, 119991 Moscow, Russia 8 National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, Institute of Medical Virology, Justus Liebig University of Giessen, 35392 Giessen, Germany; [email protected] * Correspondence: [email protected] † Co-first authors. Citation: Brezgin, S.; Kostyusheva, ‡ Co-senior authors. A.; Bayurova, E.; Volchkova, E.; Gegechkori, V.; Gordeychuk, I.; Glebe, Abstract: Viral infections cause a variety of acute and chronic human diseases, sometimes resulting D.; Kostyushev, D.; Chulanov, V. Immunity and Viral Infections: in small local outbreaks, or in some cases spreading across the globe and leading to global pandemics.
    [Show full text]
  • Endocytosis Elicited by Nectins Transfers Cytoplasmic Cargo, Including Infectious Material, Between Cells Alex R
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs235507. doi:10.1242/jcs.235507 RESEARCH ARTICLE Trans-endocytosis elicited by nectins transfers cytoplasmic cargo, including infectious material, between cells Alex R. Generous1,2, Oliver J. Harrison3, Regina B. Troyanovsky4, Mathieu Mateo1,*, Chanakha K. Navaratnarajah1, Ryan C. Donohue1,2, Christian K. Pfaller1,2, Olga Alekhina5, Alina P. Sergeeva3,6, Indrajyoti Indra4, Theresa Thornburg7,‡, Irina Kochetkova7, Daniel D. Billadeau5, Matthew P. Taylor7, Sergey M. Troyanovsky4, Barry Honig3,6, Lawrence Shapiro3 and Roberto Cattaneo1,2,§ ABSTRACT development, where the Bride of sevenless protein is internalized by the Sevenless tyrosine kinase receptor (Cagan et al., 1992). Here, we show that cells expressing the adherens junction protein Transfer of specific transmembrane proteins also occurs during nectin-1 capture nectin-4-containing membranes from the surface tissue patterning in embryonic development of higher of adjacent cells in a trans-endocytosis process. We find that vertebrates, during epithelial cell movement and at the immune internalized nectin-1–nectin-4 complexes follow the endocytic synapse (Gaitanos et al., 2016; Hudrisier et al., 2001; Marston et al., pathway. The nectin-1 cytoplasmic tail controls transfer: its deletion 2003; Matsuda et al., 2004; Qureshi et al., 2011). At the immune prevents trans-endocytosis, while its exchange with the nectin-4 tail synapse, the CTLA-4 protein captures its ligands CD80 and CD86 reverses transfer direction. Nectin-1-expressing cells acquire dye- from donor cells by a process of trans-endocytosis; after removal, labeled cytoplasmic proteins synchronously with nectin-4, a process these ligands are degraded inside the acceptor cell, resulting in most active during cell adhesion.
    [Show full text]
  • Structural and Functional Analyses of the Interaction of Tetherin with the Dendritic Cell Receptor ILT7 Nicolas Aschman
    Structural and functional analyses of the interaction of tetherin with the dendritic cell receptor ILT7 Nicolas Aschman To cite this version: Nicolas Aschman. Structural and functional analyses of the interaction of tetherin with the dendritic cell receptor ILT7. Biomolecules [q-bio.BM]. Université Grenoble Alpes, 2015. English. NNT : 2015GREAV064. tel-01682995 HAL Id: tel-01682995 https://tel.archives-ouvertes.fr/tel-01682995 Submitted on 12 Jan 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés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
    [Show full text]
  • Virion-Incorporated PSGL-1 and CD43 Inhibit Both Cell-Free Infection and Transinfection of HIV-1 by Preventing Virus–Cell Binding
    Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus–cell binding Tomoyuki Murakamia, Nancy Carmonaa, and Akira Onoa,1 aDepartment of Microbiology & Immunology, University of Michigan Medical School, Ann Arbor, MI 48109 Edited by Stephen P. Goff, Columbia University Medical Center, New York, NY, and approved February 19, 2020 (received for review September 16, 2019) HIV-1 particles incorporate various host transmembrane proteins in juxtamembrane region of these transmembrane proteins (14). addition to viral Env glycoprotein during assembly at the plasma Therefore, PSGL-1, CD43, and CD44 are likely to be specifically membrane. In polarized T cells, HIV-1 structural protein Gag localizes recruited to the sites of virus assembly via the MA domain and to the plasma membrane of uropod, a rear-end protrusion. Notably, subsequently incorporated into progeny virions. uropod transmembrane proteins PSGL-1 and CD43 cocluster specif- Our recent study demonstrated that virion-incorporated ically with Gag assembling at the plasma membrane even in cells CD44 is required for transinfection of HIV-1 mediated by − that do not form uropods. Recent reports have shown that CD4 secondary lymphoid organ stromal cells, known as fibro- expression of either PSGL-1 or CD43 in virus-producing cells reduces blastic reticular cells (FRCs) (15). In this transinfection process, the infectivity of progeny virions and that HIV-1 infection reduces virion-incorporated CD44 binds the polysaccharide hyaluronan the cell surface expression of these proteins. However, the mech- (HA), which in turn binds CD44 on the FRC surface. HIV-1 anisms for both processes remain to be determined.
    [Show full text]
  • S41467 019 10192 2.Pdf
    ARTICLE https://doi.org/10.1038/s41467-019-10192-2 OPEN The viral protein corona directs viral pathogenesis and amyloid aggregation Kariem Ezzat 1,2, Maria Pernemalm 3, Sandra Pålsson1, Thomas C. Roberts4,5, Peter Järver1, Aleksandra Dondalska1, Burcu Bestas2,18, Michal J. Sobkowiak6, Bettina Levänen7, Magnus Sköld8,9, Elizabeth A. Thompson10, Osama Saher2,11, Otto K. Kari12, Tatu Lajunen 12, Eva Sverremark Ekström 1, Caroline Nilsson13, Yevheniia Ishchenko14, Tarja Malm14, Matthew J.A. Wood4, Ultan F. Power 15, Sergej Masich16, Anders Lindén7,9, Johan K. Sandberg 6, Janne Lehtiö 3, Anna-Lena Spetz 1,19 & Samir EL Andaloussi2,4,17,19 1234567890():,; Artificial nanoparticles accumulate a protein corona layer in biological fluids, which sig- nificantly influences their bioactivity. As nanosized obligate intracellular parasites, viruses share many biophysical properties with artificial nanoparticles in extracellular environments and here we show that respiratory syncytial virus (RSV) and herpes simplex virus type 1 (HSV-1) accumulate a rich and distinctive protein corona in different biological fluids. Moreover, we show that corona pre-coating differentially affects viral infectivity and immune cell activation. In addition, we demonstrate that viruses bind amyloidogenic peptides in their corona and catalyze amyloid formation via surface-assisted heterogeneous nucleation. Importantly, we show that HSV-1 catalyzes the aggregation of the amyloid β-peptide (Aβ42), a major constituent of amyloid plaques in Alzheimer’s disease, in vitro and in animal models. Our results highlight the viral protein corona as an acquired structural layer that is critical for viral–host interactions and illustrate a mechanistic convergence between viral and amyloid pathologies. 1 Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm 10691, Sweden.
    [Show full text]
  • TLR-4 Engagement of Dendritic Cells Confers A
    TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse Fabien Blanchet, Romaine Stalder, Magdalena Czubala, Martin Lehmann, Laura Rio, Bastien Mangeat, Vincent Piguet To cite this version: Fabien Blanchet, Romaine Stalder, Magdalena Czubala, Martin Lehmann, Laura Rio, et al.. TLR- 4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse. Retrovirology, BioMed Central, 2013, 10 (1), pp.6. 10.1186/1742-4690-10-6. hal-02352285 HAL Id: hal-02352285 https://hal.archives-ouvertes.fr/hal-02352285 Submitted on 8 Jun 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Blanchet et al. Retrovirology 2013, 10:6 http://www.retrovirology.com/content/10/1/6 RESEARCH Open Access TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse Fabien P Blanchet1†, Romaine Stalder2†, Magdalena Czubala1, Martin Lehmann2, Laura Rio2, Bastien Mangeat1,2 and Vincent Piguet1* Abstract Background: Dendritic cells and their subsets, located at mucosal surfaces, are among the first immune cells to encounter disseminating pathogens.
    [Show full text]
  • 294 Immunophenotypic Subgroups of SLE Defined by Autoantibodies
    Abstracts Lupus Sci Med: first published as 10.1136/lupus-2019-lsm.294 on 1 April 2019. Downloaded from could be predicated and prevented with pre-treatment. The mature B cells and, for that reason, is considered a good raising of risk prediction models depends on the collection of target for plasma cell depletion. Here, we analyze a promis- patient phenotypes, which are scattered in various forms and ing therapeutic in development for Multiple Myeloma very cumbersome. (MM), that could be used for the treatment for SLE. The In this study, we collected the largest database of complete antiCD3*BCMA bispecific antibody TNB-383B is in clinical medical record of inpatients of lupus in China. The clinical trials for the treatment of MM. In vitro experiment showed phenotype database was generated by using natural language that TNB-383B added to human bone marrow samples ex processing (NLP) techniques, then lupus nephritis (LN) predic- vivo induced a dose dependent lysis of BCMA-expressing tion model was built. plasma cells. Methods A total of 14,439 SLE patients were collected from Methods Depletion of plasma cells by TNB-383B was tested the rheumatology and immunology departments of 13 Chi- using bone marrow samples extracted from bone retrieved nese tertiary hospitals in this study, including 13 062 females of hip replacments. Human bone marrow mononuclear cells (90.46%), with an average age of 33.4 years, and the time (n=10) were incubated with TNB-383B at increasing con- span of EMR (Electronic Medical Records) was from Octo- centrations. The activity of TNB-383B was compared to a ber 28, 2001 to March 31, 2017.
    [Show full text]
  • 1 Running Head B-Cell Tetherin Predicts SLE Disease
    bioRxiv preprint doi: https://doi.org/10.1101/554352; this version posted February 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Running Head B-Cell Tetherin predicts SLE disease activity Title B cell tetherin: a flow-cytometric cell-specific assay for response to Type-I interferon predicts clinical features and flares in SLE Authors Yasser M. El-Sherbiny, MBBCh, MSc, PhD,1,2,3 Md. Yuzaiful Md. Yusof, MBChB, MRCP,1,7 Antonios Psarras, MD, MSc,1,7 Elizabeth M. A. Hensor, PhD,1,7 Kumba Z. Kabba, MSc,1 Katherine Dutton, MBBS, BMedSc,1,7 Alaa A.A. Mohamed, MBBCh, MSc, MD,1,4 Dirk Elewaut, MD, PhD,5 Dennis McGonagle, MD, PhD,1,7 Reuben Tooze, PhD,5 Gina Doody, PhD,5 Miriam Wittmann, MD,1,7 Paul Emery, MA, MD, FMedSci,1,7 Edward M. Vital, PhD, MRCP1,7 Affiliations 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; 2School of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, UK; 3Clinical Pathology Department, Faculty of Medicine, Mansoura University, Egypt; 4Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University, Egypt; 5Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK; 6Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; 7National Institute of Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Correspondence Dr Edward M Vital Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds LS7 4SA, UK Telephone: +44 113 3924964 Email: [email protected] Funding This work was supported by the National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit.
    [Show full text]
  • Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy
    International Journal of Molecular Sciences Review Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy Kiruphagaran Thangaraju 1,†, Sabari Nath Neerukonda 2,3,† , Upendra Katneni 1,* and Paul W. Buehler 1,4 1 Center for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA; [email protected] (K.T.); [email protected] (P.W.B.) 2 Department of Animal and Food Sciences, University of Delaware, Newark, DE 19716, USA; [email protected] 3 Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA 4 Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA * Correspondence: [email protected]; Tel.: +1-4107067088 † The authors contributed equally to this work. Abstract: Red blood cells (RBCs) release extracellular vesicles (EVs) including both endosome- derived exosomes and plasma-membrane-derived microvesicles (MVs). RBC-derived EVs (RBCEVs) are secreted during erythropoiesis, physiological cellular aging, disease conditions, and in response to environmental stressors. RBCEVs are enriched in various bioactive molecules that facilitate cell to cell communication and can act as markers of disease. RBCEVs contribute towards physiological adaptive responses to hypoxia as well as pathophysiological progression of diabetes and genetic non-malignant hematologic disease. Moreover, a considerable number of studies focus on the role of EVs from stored RBCs and have evaluated post transfusion consequences associated with their exposure. Interestingly, RBCEVs are important contributors toward coagulopathy in hematological disorders, thus representing a unique evolving area of study that can provide insights into molec- Citation: Thangaraju, K.; ular mechanisms that contribute toward dysregulated hemostasis associated with several disease Neerukonda, S.N.; Katneni, U.; conditions.
    [Show full text]